NWU Institutional Repository

Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review

dc.contributor.authorNokuthula L, Makhene,
dc.contributor.authorSteyn, Hanlie
dc.contributor.authorVorster, Martine
dc.contributor.authorLubbe, Martie S
dc.contributor.authorBurger, Johanita R.
dc.date.accessioned2023-05-04T10:03:15Z
dc.date.available2023-05-04T10:03:15Z
dc.date.issued2023
dc.description.abstractIntroduction: National regulatory systems in Southern Africa reflect various stages of maturity, and pharmacovigilance (PV) practices are not aligned. In the absence of guidance for formulating PV guidelines in Southern African Development Community (SADC) countries, this study aimed to create a checklist that may be used to assess the rigour of PV guidelines in this region and provide guidance for the National Medicines Regulatory Agency (NMRA) authors. Methods: A document analysis was performed based on harmonised international guidelines (n=22) that prescribed methods of PV regulation to identify themes and items to incorporate into a checklist. The contextualisation of the checklist to the African pharmaceutical environment was accomplished by referencing peer-reviewed journal articles (n=7). The checklist was subjected to face and content validation by non-experts and PV experts. Results: The document review yielded 5 themes, 18 sub-themes, and 73 items structured into the checklist. Themes encompassed PV systems, definitions, individual case safety reporting, aggregate reporting, and risk management. Under PV systems, aspects of the quality management system were outlined, that is, the legal basis for PV, a description of the marketing authorisation holder's (MAH's) PV system, archiving of data, contracting of PV tasks, and the duties of the person responsible for the MAH's PV obligations. Definitions of the key terms and major stakeholders were identified. Reporting of individual case safety reports (ICSRs) was explicated by considering the criteria for reporting, categories of reportable information, expedited reporting requirements, reporting timelines, and ICSR reporting format. Aggregate report submission during the development and post-marketing phases was addressed. Risk management encompassed signal detection, re-evaluation of the benefit-risk ratio, the safety decision-making process, risk management planning, risk minimisation and safety communication. Conclusion: The developed checklist can contribute towards assisting SADC NMRAs to formulate national PV guidelines that reflect current international practice, with local context incorporated.en_US
dc.identifier.citationNokuthula L. Makhene, Hanlie Steyn, Martine Vorster, Martie S. Lubbe and Johanita R. Burger. 2023. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.https://doi.org/10.1177/20420986221143272en_US
dc.identifier.urihttps://doi.org/10.1177/20420986221143272
dc.identifier.urihttp://hdl.handle.net/10394/41228
dc.language.isoenen_US
dc.publisherSageen_US
dc.subjectchecklisten_US
dc.subjectdocument analysisen_US
dc.subjectguidelinesen_US
dc.subjectpharmacovigilanceen_US
dc.subjectSouthern African Development Communityen_US
dc.titleDevelopment of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document reviewen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nokuthula L. Makhene_ Development of a checklist.pdf
Size:
909.57 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections